Dong-A Pharm nine-month sales rises 13%

Dong-A Pharm, Korea's leading drug maker, said it posted sales of 412.3 billion won for the nine months of this year, up 13.19 percent compared with 364.2 billion won a year ago, due to continued robust sales of prescription drugs such as Stilene, Gaster and Epocerin, albeit sluggish sales in OTC products.

The nine-month operating profit rose 26 percent to 35.1 billion won and net income jum...